NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
5.10
-0.09 (-1.73%)
Aug 14, 2025, 11:25 AM - Market open
NextCure Employees
NextCure had 43 employees as of December 31, 2024. The number of employees decreased by 39 or -47.56% compared to the previous year.
Employees
43
Change (1Y)
-39
Growth (1Y)
-47.56%
Revenue / Employee
n/a
Profits / Employee
-$1,416,907
Market Cap
13.65M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 43 | -39 | -47.56% |
Dec 31, 2023 | 82 | -17 | -17.17% |
Dec 31, 2022 | 99 | 12 | 13.79% |
Dec 31, 2021 | 87 | -3 | -3.33% |
Dec 31, 2020 | 90 | 21 | 30.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NXTC News
- 6 days ago - NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 20 days ago - Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta - GlobeNewsWire
- 2 months ago - NextCure signs up to $745 million deal with China's Simcere to develop cancer drug - Reuters
- 2 months ago - NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6 - GlobeNewsWire
- 2 months ago - NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025 - GlobeNewsWire
- 3 months ago - NextCure Provides Business Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - NextCure to Present at 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 months ago - NextCure Provides Business Update and Reports Full Year 2024 Financial Results - GlobeNewsWire